Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RARE DISEASE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00640289
What this trial is testing

Clinical Trial of Factor XIII (FXIII) Concentrate

Who this might be right for
HemophiliaFactor XIII Deficiency
Children's Hospital of Orange County 72
Not applicableStudy completedNCT05028894
What this trial is testing

23andMe IPF Research Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
23andMe, Inc. 690
Not applicableStudy completedNCT07573072
What this trial is testing

Characterization of the Methylation Profile of Stored Human Samples

Who this might be right for
Rare DisordersSarcoma of Bone and Connective TissueInflammatory Articular Diseases
Istituto Ortopedico Rizzoli 90
Testing effectiveness (Phase 2)UnknownNCT00004375
What this trial is testing

Ultraviolet Light Therapy for Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Center for Research Resources (NCRR) 20
Testing effectiveness (Phase 2)Study completedNCT00004437
What this trial is testing

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Who this might be right for
Neurofibromatosis 2
FDA Office of Orphan Products Development
Not applicableUnknownNCT03199001
What this trial is testing

Native T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Rare Diseases

Who this might be right for
Fabry Disease
University College, London 400
Not applicableLooking for participantsNCT05247645
What this trial is testing

Data Collection of Patients With Rare Bone Diseases

Who this might be right for
Skeletal Dysplasia
Luca Sangiorgi 1,000
Post-approval studies (Phase 4)Looking for participantsNCT07746895
What this trial is testing

Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study

Who this might be right for
C3 Glomerulopathy (C3G)Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Swedish Orphan Biovitrum 150
Not applicableStudy completedNCT04154891
What this trial is testing

Genome Sequencing Strategies for Genetics Diagnosis of Patients With Intellectual Disability

Who this might be right for
Intellectual Disability
Institut National de la Santé Et de la Recherche Médicale, France 3,825
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Study completedNCT01833832
What this trial is testing

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaPeritoneal Carcinomatosis
National Cancer Institute (NCI) 11
Post-approval studies (Phase 4)Looking for participantsNCT03340506
What this trial is testing

Dabrafenib and/or Trametinib Rollover Study

Who this might be right for
MelanomaNon Small Cell Lung CancerSolid Tumor+2 more
Novartis Pharmaceuticals 100
Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Not applicableStudy completedNCT06523998
What this trial is testing

A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.

Who this might be right for
SporotrichosisChromomycosisActinomycosis+7 more
Caja Costarricense de Seguro Social 95
Large-scale testing (Phase 3)Study completedNCT01908816
What this trial is testing

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Who this might be right for
Choroidal NeovascularizationMacular EdemaGlaucoma, Neovascular+1 more
Novartis Pharmaceuticals 270
Not applicableLooking for participantsNCT03416114
What this trial is testing

RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres

Who this might be right for
Headache Disorders
Silvia Benemei 3,000
Not applicableUnknownNCT02558478
What this trial is testing

Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing

Who this might be right for
Neurosensory DiseasesRetinopathyHearing Loss
University Hospital, Strasbourg, France 39
Not applicableStudy completedNCT04382820
What this trial is testing

Psychosocial Situation of Children With Rare (Congenital) Pediatric Surgical Diseases and Their Families

Who this might be right for
Rare Diseases
Universitätsklinikum Hamburg-Eppendorf 167
Not applicableStudy completedNCT00004410
What this trial is testing

Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants

Who this might be right for
Cholestasis
Children's Hospital Medical Center, Cincinnati 50
Testing effectiveness (Phase 2)Looking for participantsNCT05967689
What this trial is testing

Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Who this might be right for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc. 220
Next Page